Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index; 30 of the 58 sources its claims cite were checked for support.

Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics

Open access
Hovmand, Oliver Rumle, Poulsen, Emil Deleuran, Arnfred, Sidse · 2024 · Journal of Psychopharmacology

Abstract

The classical psychedelics psilocybin, peyote, ayahuasca/ N, N-dimethyltryptamine, and lysergic acid diethylamide can temporarily produce altered states of consciousness, characterized by changes in sensory perception, thought, mood, and the sense of self-reality and meaning. It is important to have reliable instruments for quantifying these altered states in trials, due to a plausible link between the acute subjective experience and treatment outcome. Methods: We conducted a review of outcome measures applied in research on classical psychedelics to assess one or more dimensions of the acute subjective psychedelic experience. Three relevant databases were searched electronically. Two reviewers independently conducted article selection and data extraction regarding the instruments, dimensions, geography, population, and psychedelic substance investigated in the included studies. We identified the five most utilized instruments for the most recent 6 years, as well as the five most utilized instruments for each psychedelic. Results: We included 93 papers, which reported on 93 unique trials and utilized 17 different rating scales. Of these, the most utilized were the Five-Dimensional Altered States of Consciousness Questionnaire, visual analog or Likert scales specially developed for the trials, the Hallucinogen Rating Scale, the States of Consciousness Questionnaire, and the Abnormer Psychischer Zustand. Discussion: Considerable variability was found in the instruments utilized in clinical trials on classical psychedelics.

Overview

CoChat Summary

TL;DR

This review mapped patient-reported outcome measures used to assess the acute subjective psychedelic experience in clinical research on classical psychedelics. Across 93 papers/trials, the authors found 17 instruments and substantial heterogeneity, with the 5D-ASC and HRS used most often.

Key findings

  • The review included 93 papers, representing 93 unique trials, and identified 17 different rating scales; it also identified 4 emerging instruments.
  • The most used instruments across all trials were the 5D-ASC (54 trials, 58%), purpose-made VAS/Likert instruments (27 trials, 29%), the HRS (23 trials, 25%), the MEQ30 (15 trials, 16%), and the SOCQ (14 trials, 15%).
  • In the most recent 8 years (2016–2023), 62% of the 93 trials were published; the most used instruments in that subset were the 5D-ASC (40 trials, 69%), PurposeM (20 trials, 34%), the MEQ30 (15 trials, 26%), and the HRS and SOCQ (9 trials each, 16%).
  • By substance, psilocybin accounted for 56% of included studies, LSD for 25%, and ayahuasca/DMT for 17%; the 5D-ASC dominated psilocybin and LSD studies, while the HRS was most used in DMT/ayahuasca studies (81% of that subsample).

Methods

  • The authors conducted a review of outcome measures used to assess one or more dimensions of the acute subjective psychedelic experience in clinical research on classical psychedelics.
  • They searched PubMed, Embase, and APA PsycNet from January 1, 1990 to May 22, 2023, and included peer-reviewed English or Danish human clinical studies using psilocybin, DMT/ayahuasca, LSD, or mescaline.
  • Two reviewers independently screened and extracted data on instruments, dimensions, geography, population, and substance; they also grouped instrument content into seven domains and summarized frequencies of use.

Limitations

  • The paper states that it did not systematically search protocols or trial registers, so it may have underestimated instrument use because some measures could have been used but not reported in the primary papers.
  • The authors note that their description of instrument validity is possibly incomplete because it was based on hand-searching included trials only.
  • The grouping of items into domains is limited by the authors’ interpretation and not by other stakeholders; this is an explicit limitation stated in the paper.
  • Evident from the text: the review excluded microdosing studies and some more generic psychiatric scales, so its findings do not cover all possible subjective-effect measures used in psychedelic research.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1177/02698811231200019

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. PRISMA 2020 flow diagram with reasons for exclusion. PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Figure 1. PRISMA 2020 flow diagram with reasons for exclusion. PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses.CC BY-NC · PubMed Central

Verification

Claims the paper makes

26 Valid · 2 Not valid · 16 Not checked · 29 Own results and interpretations

19 more claims · 3 with their cited sources checked

Create a free account to see all 73 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 39
  • Probably not a substantial claim. 21

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 68 references

Research works printed but not linked: 15

  1. Bodmer I, 1989, Konstruktion des Fragebogens OAV zut quantitativen Erfassung auβergewöhnlicher Bewuβtseinszustände (ABZ)
  2. Dittrich A, 1975, Z Klin Psychol Psychiatr Psychother, 23, 12
  3. Dittrich A, 1996, Ätiologie-unabhängige Strukturen veränderter Wachbewusstseinszustände.Ergebnisse empirischer Untersuchungen über Halluzinogene I. und II. Ordnung, sensorische Deprivation, hypnagoge Zustände, hypnotische Verfahren sowie Reizüberflutung [Etiology-independent structures of altered states of consciousness. Results of empirical studies on hallucinogens of the first and second order, sensory deprivation, hypnagogic states, hypnotic procedures, and sensory overload]
  4. Dittrich A, 2006, 5D-ABZ: Fragebogen zur Erfassung Aussergewöhnlicher Bewusstseinszustände. Eine kurze Einführung [5D-ASC: Questionnaire for the assessment of altered states of consciousness. A short introduction]
  5. Dittrich A, 2010, 5D-ASC: Questionnaire for the Assessment of Altered States of Consciousness. A Short Introduction
  6. Dittrich A, 1985, Ger J Psychol, 9, 319
  7. Fauvel B, 2022, J Psychoactive Drugs, 6, 1
  8. Francis LJ, 2001, Res Social Sci Study Relig, 11, 99
  9. Janke W, 1978, Die Eigenschaftswrterliste (EWL-K)— Ein Verfahren zur Erfassung der Befindlichkeit
  10. Leary T, 1962, Joyous Cosmol. Advent. Chem. Consciousn, 1
  11. Luna LE, 2011, Ethnopharmacol Ayahuasca, 2, 1
  12. Overall JE, 1988, Psychopharmacology Bulletin, 22, 97
  13. Pahnke WN, 1969, Int Psychiatry Clin, 5, 149
  14. Richards WA, 1975, Counseling, peak experiences and the human encounter with death: An empirical study of the efficacy of DPT-assistance counseling in enhancing quality of life of persons with terminal cancer and their closest family members
  15. Zinberg NE, 1984, Drug, Set, and Setting: The Basis for Controlled Intoxicant Use.

Cited by

See all 33

Metadata

Authors
Hovmand, O. R., Poulsen, E. D., & Arnfred, S.
Affiliations
  • University of Copenhagen (DK)
  • Copenhagen University Hospital (DK)
Corresponding author
Hovmand, Oliver Rumle
Venue
Journal of Psychopharmacology
Published
2023-11-16
Volume
38
Issue
1
Pages
19-32
ISSN
  • 0269-8811 (ISSN-L)
  • 1461-7285
OpenAlex
W4388731626
Cited by
33
References
68
Citations by year
2026: 11 · 2025: 15 · 2024: 7
FWCI
1.67
Type
journal article
Language
en
Open access
Locations
  • Journal of Psychopharmacology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
  • Social Sciences › Health › Religion, Spirituality, and Psychology
Keywords
classical psychedelics, patient-reported outcome measures, altered states of consciousness, psilocybin, peyote, ayahuasca, N,N-dimethyltryptamine, lysergic acid diethylamide, rating scales, core outcome set
MeSH terms
Patient Reported Outcome Measures, N,N-Dimethyltryptamine, Hallucinogens, Humans, Lysergic Acid Diethylamide, Psilocybin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics. https://app.cochat.ai/papers/10.1177/02698811231200019
The paper
Hovmand, O. R., Poulsen, E. D., & Arnfred, S. (2024). Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics. Journal of Psychopharmacology. https://doi.org/10.1177/02698811231200019

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.